CAR T-Cell Therapy: Engineering Patients’ Immune Cells to Treat Their Cancers

For years, the cornerstones of cancer treatment have been surgery, chemotherapy, and radiation therapy. Over the last decade, targeted therapies like imatinib (Gleevec®) and trastuzumab (Herceptin®)—drugs that target cancer cells by homing in on specific molecular changes seen primarily in those cells—have also emerged as standard treatments for a number of cancers. 阅读更多 (Read More)

Read more

免责声明:

WEBSITE DISCLAIMER: 福建医科大学美国校友会 (AAFMUA) 网站始建于2000年。本网站所有转载的文章,不代表AAFMUA或本网站的官方立场,仅是为读者提供阅读方便,因此我们对外来的文章的内容一概不负责任。